Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
11.91
-0.32 (-2.62%)
Aug 18, 2026, 12:25 PM EDT - Market open

Vicore Pharma Holding AB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
327345179158141110
Market Cap Growth
15.02%92.70%13.69%12.08%27.22%-52.33%
Enterprise Value
21625414510312461

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
882.97833.4418.13---
PB Ratio
3.142.901.763.485.072.61
P/TBV Ratio
3.142.901.763.506.633.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
582.98614.4614.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----00.00
Net Debt / Equity Ratio
-1.07-1.06-1.02-1.06-0.90-0.97
Net Debt / EBITDA Ratio
-2.586.151.520.921.28
Net Debt / FCF Ratio
2.603.117.011.930.871.40
Asset Turnover
0.000.000.13---
Quick Ratio
12.579.9917.9011.865.695.67
Current Ratio
12.6910.2818.2012.105.815.75
Return on Equity (ROE)
-47.19%-42.92%-21.28%-83.53%-85.79%-80.37%
Return on Assets (ROA)
-28.12%-23.53%-14.05%-47.99%-45.54%-42.76%
Return on Capital Employed (ROCE)
-49.00%-41.30%-16.80%-70.20%-98.60%-76.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.24%-15.01%-8.51%-19.63%-19.69%-29.68%
FCF Yield
-13.06%-11.81%-8.32%-15.75%-20.47%-26.55%
Buyback Yield / Dilution
-50.17%-75.30%-41.72%-33.71%-3.64%-28.44%